Table 1. Licensed indications, mechanism of action and comparative tolerability and side effects of SSRIs.[77].
FDA approved year | FDA therapeuticindications | Mechanism of action | Cardiovascular profile | |
Citalopram | 1998 | Major depressive disorder | A highly selective and potent serotonin reuptake inhibitor | Uncommon (≥ 1/1000 to <1/100): bradycardia, orthostatic hypotension, tachycardia; Rare (≥ 1/10000 to <1/1000): atrial fibrillation, bundle branch block, cardiac arrest, hypertension, myocardial infarction, phlebitis, transient ischemic attacks, stroke |
Escitalopram | 2002 | Major depressive disorder; generalized anxiety disorder | More selective serotonin reuptake inhibitor than citalopram | Uncommon (≥ 1/1000 to <1/100): tachycardia;Rare (≥ 1/10000 to <1/1000): bradicardia, orthostatic hypotension |
Fluoxetine | 1987 | Bulimia nervosa; major depressive disorder; obsessive compulsive disorder; panic disorder; premestrual dysphoric disorder | Potent and selective inhibitor of serotonin reuptake with antidepressant, antiobsessional and antibulimic effects | Uncommon (≥ 1/1000 to <1/100): junctional rhytms, mild bradycardia, sinus tachycardia, ventricular trigeminy; Rare (≥ 1/10000 to <1/1000): ECG abnormalities, thrombophlebitis |
Fluvoxamine | 1993 | Major depressive disorder; obsessive compulsive disorder | A selective serotonin reuptake inhibitor with affinity for the serotonin transporter over the norepinephrine transporter | Uncommon (≥ 1/1000 to <1/100): ST segment changes, atrioventricular and supraventricular blockade; Rare (≥ 1/10000 to <1/1000): coronary heart disease, embolus, pericarditis, phlebitis, pulmonaty infarction, stroke |
Paroxetine | 1992 | Generalized anxiety disorder; major depressive disorder; obsessive compulsive disorder; panic disorder; post-traumatic stress disorder; premestrual dysphoric disorder; social anxiety disorder | The most potent inhibitor of the reuptake of serotonin | Uncommon (≥ 1/1000 to <1/100): hypertension, syncope, tachycardia; Rare (≥ 1/10000 to <1/1000): angina pectoris, bradycardia, congestive heart failure, hypotension, myocardial infarction, thrombophlebitis, vascular headache |
Sertraline | 1991 | Major depressive disorder; obsessive compulsive disorder; panic disorder; post-traumatic stress disorder; premestrual dysphoric disorder; social phobia | Selective inhibitor of the reuptake of serotonin and a weak activity in inhibiting the reuptake of dopamine | Uncommon (≥ 1/1000 to <1/100): hypertension, postural hypoternsion, tachycardia;Rare (≥ 1/10000 to <1/1000): angina pectoris, bradycardia, myocardial infarction, stroke |
SSRIs: Selective serotonin reuptake inhibitors; FDA: Food and Drug Administration; ECG: Electrocardiogram.